Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-01-09 to 2024-01-10
Current total value of award: $50.52
Description: 4563277462!LORAZEPAM 2 MG/ML VIALML